Kodiak Sciences (KOD)’ tabirafusp alfa was granted FDA orphan designation as a treatment of uveitic macular edema, according to a post to the agency’s website.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.